Bas de contention : Questions médicales fréquentes
Nom anglais: Stockings, Compression
Descriptor UI:D053828
Tree Number:E07.101.400.500
Termes MeSH sélectionnés :
Programmed Cell Death 1 Receptor
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bas de contention : Questions médicales les plus fréquentes",
"headline": "Bas de contention : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bas de contention : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-12",
"dateModified": "2025-05-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bas de contention"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Bandages de compression",
"url": "https://questionsmedicales.fr/mesh/D058128",
"about": {
"@type": "MedicalCondition",
"name": "Bandages de compression",
"code": {
"@type": "MedicalCode",
"code": "D058128",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E07.101.400"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Bas de contention",
"alternateName": "Stockings, Compression",
"code": {
"@type": "MedicalCode",
"code": "D053828",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Moacir Marocolo",
"url": "https://questionsmedicales.fr/author/Moacir%20Marocolo",
"affiliation": {
"@type": "Organization",
"name": "e Physiology and Human Performance Research Group, Department of Physiology , Federal University of Juiz de Fora , Juiz de For a , Brazil."
}
},
{
"@type": "Person",
"name": "Jichun Zhao",
"url": "https://questionsmedicales.fr/author/Jichun%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "Department of Vascular Surgery, West China Hospital, Sichuan University, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Wen-Tao Yang",
"url": "https://questionsmedicales.fr/author/Wen-Tao%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Vascular Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."
}
},
{
"@type": "Person",
"name": "Hua-Liang Ren",
"url": "https://questionsmedicales.fr/author/Hua-Liang%20Ren",
"affiliation": {
"@type": "Organization",
"name": "Department of Vascular Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Programmed cell death-1 blockade therapy in melanoma: Resistance mechanisms and combination strategies.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36645031",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/exd.14750"
}
},
{
"@type": "ScholarlyArticle",
"name": "MicroRNAs Targeting Programmed Cell Death Protein 1 (PD-1) Promote Natural Killer Cell Exhaustion in Rheumatoid Arthritis.",
"datePublished": "2022-12-24",
"url": "https://questionsmedicales.fr/article/36640056",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18502/ijaai.v21i6.11524"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy.",
"datePublished": "2023-04-21",
"url": "https://questionsmedicales.fr/article/37153623",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1138145"
}
},
{
"@type": "ScholarlyArticle",
"name": "A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/35758515",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2340/actadv.v102.1062"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36442821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.actbio.2022.11.043"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Équipement et fournitures",
"item": "https://questionsmedicales.fr/mesh/D004864"
},
{
"@type": "ListItem",
"position": 3,
"name": "Bandages",
"item": "https://questionsmedicales.fr/mesh/D001458"
},
{
"@type": "ListItem",
"position": 4,
"name": "Bandages de compression",
"item": "https://questionsmedicales.fr/mesh/D058128"
},
{
"@type": "ListItem",
"position": 5,
"name": "Bas de contention",
"item": "https://questionsmedicales.fr/mesh/D053828"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bas de contention - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bas de contention",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bas de contention",
"description": "Comment diagnostiquer une insuffisance veineuse ?\nQuels signes indiquent le besoin de bas de contention ?\nQuels tests sont nécessaires avant de prescrire des bas de contention ?\nLes bas de contention sont-ils adaptés à tous les patients ?\nComment évaluer l'efficacité des bas de contention ?",
"url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bas de contention",
"description": "Quels symptômes nécessitent des bas de contention ?\nLes bas de contention soulagent-ils les crampes ?\nComment les bas de contention affectent-ils l'enflure ?\nLes bas de contention soulagent-ils les démangeaisons ?\nLes bas de contention améliorent-ils la fatigue des jambes ?",
"url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bas de contention",
"description": "Comment prévenir les problèmes veineux ?\nLes bas de contention sont-ils efficaces pour prévenir les varices ?\nQuelles habitudes de vie favorisent la santé veineuse ?\nLes bas de contention sont-ils recommandés pour les voyages longs ?\nComment l'alimentation influence-t-elle la santé veineuse ?",
"url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bas de contention",
"description": "Comment choisir la taille des bas de contention ?\nQuelle est la durée de port recommandée pour les bas de contention ?\nLes bas de contention sont-ils remboursés par la sécurité sociale ?\nPeut-on porter des bas de contention pendant la grossesse ?\nLes bas de contention sont-ils disponibles en différentes classes ?",
"url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bas de contention",
"description": "Quelles complications peuvent survenir avec des bas de contention ?\nLes bas de contention peuvent-ils aggraver certaines conditions ?\nComment reconnaître une mauvaise utilisation des bas de contention ?\nLes bas de contention peuvent-ils causer des thromboses ?\nQue faire en cas de réaction allergique aux bas de contention ?",
"url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bas de contention",
"description": "Quels sont les facteurs de risque pour les problèmes veineux ?\nLe tabagisme influence-t-il la santé veineuse ?\nLes femmes sont-elles plus à risque de problèmes veineux ?\nL'hérédité joue-t-elle un rôle dans les problèmes veineux ?\nLes professions sédentaires augmentent-elles le risque veineux ?",
"url": "https://questionsmedicales.fr/mesh/D053828?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une insuffisance veineuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen clinique et des tests comme l'échographie Doppler sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent le besoin de bas de contention ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs, des œdèmes et des varices visibles."
}
},
{
"@type": "Question",
"name": "Quels tests sont nécessaires avant de prescrire des bas de contention ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation de la circulation sanguine et un historique médical sont essentiels."
}
},
{
"@type": "Question",
"name": "Les bas de contention sont-ils adaptés à tous les patients ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certaines conditions comme l'artérite peuvent contre-indiquer leur usage."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des bas de contention ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'amélioration des symptômes et des examens de suivi permettent d'évaluer leur efficacité."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent des bas de contention ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs, lourdeur des jambes, œdèmes et varices sont des symptômes fréquents."
}
},
{
"@type": "Question",
"name": "Les bas de contention soulagent-ils les crampes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire les crampes nocturnes en améliorant la circulation."
}
},
{
"@type": "Question",
"name": "Comment les bas de contention affectent-ils l'enflure ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils exercent une pression qui aide à réduire l'enflure en favorisant le retour veineux."
}
},
{
"@type": "Question",
"name": "Les bas de contention soulagent-ils les démangeaisons ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent aider à réduire les démangeaisons causées par une mauvaise circulation."
}
},
{
"@type": "Question",
"name": "Les bas de contention améliorent-ils la fatigue des jambes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire la fatigue en soutenant les veines et en améliorant la circulation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les problèmes veineux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier, l'hydratation et le port de bas de contention aident à prévenir."
}
},
{
"@type": "Question",
"name": "Les bas de contention sont-ils efficaces pour prévenir les varices ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à prévenir l'apparition des varices en soutenant les veines."
}
},
{
"@type": "Question",
"name": "Quelles habitudes de vie favorisent la santé veineuse ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter la sédentarité, maintenir un poids santé et éviter le tabac sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Les bas de contention sont-ils recommandés pour les voyages longs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont conseillés pour réduire le risque de thrombose lors de longs voyages."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle la santé veineuse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fibres et en antioxydants favorise la santé veineuse."
}
},
{
"@type": "Question",
"name": "Comment choisir la taille des bas de contention ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La taille se détermine par des mesures des jambes, comme le tour de cheville et de mollet."
}
},
{
"@type": "Question",
"name": "Quelle est la durée de port recommandée pour les bas de contention ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils doivent être portés toute la journée, retirés la nuit, sauf avis contraire du médecin."
}
},
{
"@type": "Question",
"name": "Les bas de contention sont-ils remboursés par la sécurité sociale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sous certaines conditions, notamment sur prescription médicale."
}
},
{
"@type": "Question",
"name": "Peut-on porter des bas de contention pendant la grossesse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent recommandés pour soulager les jambes pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Les bas de contention sont-ils disponibles en différentes classes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils existent en plusieurs classes de compression selon les besoins médicaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des bas de contention ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des irritations cutanées, des douleurs ou des problèmes circulatoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les bas de contention peuvent-ils aggraver certaines conditions ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aggraver des problèmes comme l'artérite ou des infections cutanées."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une mauvaise utilisation des bas de contention ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs accrues, des engourdissements ou des rougeurs peuvent indiquer une mauvaise utilisation."
}
},
{
"@type": "Question",
"name": "Les bas de contention peuvent-ils causer des thromboses ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais une mauvaise utilisation peut augmenter le risque de thrombose veineuse."
}
},
{
"@type": "Question",
"name": "Que faire en cas de réaction allergique aux bas de contention ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Retirer les bas et consulter un médecin pour évaluer la réaction et les alternatives."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les problèmes veineux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, la sédentarité, l'âge avancé et les antécédents familiaux sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la santé veineuse ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut aggraver les problèmes veineux en altérant la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque de problèmes veineux ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison des changements hormonaux, les femmes sont souvent plus à risque."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans les problèmes veineux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de varices ou d'insuffisance veineuse augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les professions sédentaires augmentent-elles le risque veineux ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, rester assis longtemps peut favoriser l'apparition de problèmes veineux."
}
}
]
}
]
}
Melanoma is a highly aggressive tumor derived from melanocytes. In recent years, the incidence and mortality of melanoma have gradually increased, seriously threatening human health. Classic treatment...
Natural killer (NK) cells play a role in the pathogenesis of rheumatoid arthritis (RA). Upregulated levels of programmed cell death protein 1 (PD-1) is a sign of exhausted NK cells that could be regul...
Erythroderma is challenging to diagnose. The aim of this single-centre retrospective study was to identify factors that can be used to improve the diagnosis of erythroderma. Among 91 patients with ery...
Immune checkpoint blockade therapy targeting programmed death-1 (PD-1) or its major ligand programmed death-ligand 1 (PD-L1) has achieved remarkable success in the treatment of several tumors, includi...
The immune system uses various immune checkpoint axes to adjust responses, support homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung carcinoma (NSCLC) can use ...
Pembrolizumab or nivolumab plus chemotherapy was approved as a first-line treatment for high programmed cell death ligand 1 (PD-L1)-expressing esophageal squamous cell carcinoma (ESCC) by the European...
Post hoc analysis of the Chinese JUPITER-06 study focusing on efficacy stratified by PD-L1 tumor proportion score (TPS; using JS311 antibody) was conducted. Electronic databases were searched to ident...
The post hoc analysis of JUPITER-06 showed more prominent clinical benefit with PD-1 antibody plus chemotherapy than with chemotherapy alone in both the high and low PD-L1-expressing subgroups. Five r...
This study provided novel evidence supporting the superiority of PD-1 antibody plus chemotherapy to chemotherapy alone in patients with advanced ESCC with low PD-L1 expression. Further studies of pred...
Major depression (MD) may be associated with inflammation and immunity. PD-1 (programmed death-1), PD-L1 (programmed death-ligand 1) and PD-L2 (programmed death-ligand 2) are among the inhibitory immu...
During a period of 2 years, patients with MD and healthy controls were recruited from a medical centre in this study. The diagnosis of MD was established according to the DSM-5 criteria. The severity ...
A total of 54 patients with MD and 38 healthy controls were recruited. According to the analyses, there is a significantly higher PD-L2 level in MD than in healthy controls and lower PD-1 level after ...
It was found that PD-1 pathway might play an important role in MD. We need a large sample to prove these results in the future....
Tumor-infiltrating lymphocytes are detectable in up to 75% of triple-negative breast cancer. The composition of these infiltrates may influence prognosis and is not known regarding regulatory or effec...
This was a retrospective observational study. Clinical and pathological data from 38 triple-negative breast cancer patients treated with neoadjuvant chemotherapy at the University Hospital (HUCFF/UFRJ...
Statistically significant changes in stromal tumor-infiltrating lymphocyte categories were observed before and post-neoadjuvant chemotherapy, with 32% of intermediate cases becoming high. The correlat...
In this study, we observed that chemotherapy significantly increases stromal tumor-infiltrating lymphocytes, CD8 T cells, as well as CD8/FoxP3 ratio. Most importantly, programmed cell death protein 1 ...
Melanoma is widely treated with programmed cell death-1 (PD-1) inhibitors. As part of their anti-tumor immunity effect, they increase the susceptibility to cutaneous immune-related adverse events (cIR...